103775-10-6,MFCD00865878
Catalog No.:AA01DQ6Y

103775-10-6 | 3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
1 week  
$697.00   $488.00
- +
50mg
1 week  
$1,322.00   $925.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01DQ6Y
Chemical Name:
3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-
CAS Number:
103775-10-6
MDL Number:
MFCD00865878
Properties
Computed Properties
 
Complexity:
742  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
12  
XLogP3:
1.2  

Literature

Title: A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma.

Journal: Biomedical chromatography : BMC 20121201

Title: Correlation between ultra-high performance liquid chromatography-tandem mass spectrometry and reversed-phase thin-layer chromatography hydrophobicity data for evaluation of angiotensin-converting enzyme inhibitors absorption.

Journal: Journal of chromatography. A 20121005

Title: Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.

Journal: Bioorganic & medicinal chemistry letters 20120115

Title: Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.

Journal: Journal of fluorescence 20120101

Title: Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

Journal: PloS one 20120101

Title: First order derivative spectrophotometric and HPLC methods for determination of moexipril hydrochloride in the pure form, pharmeceutical formulations and evaluation of its stability.

Journal: Acta poloniae pharmaceutica 20120101

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertension.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20110101

Title: Scope of claim coverage in patents of fufang Chinese herbal drugs: Substitution of ingredients.

Journal: Chinese medicine 20110101

Title: Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.

Journal: PloS one 20110101

Title: Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Journal: Healthcare informatics research 20101201

Title: Anti-hypertensive drugs have different effects on ventricular hypertrophy regression.

Journal: Clinics (Sao Paulo, Brazil) 20100701

Title: Determination of antihypertensive drug moexipril hydrochloride based on the enhancement effect of sodium dodecyl sulfate at carbon paste electrode.

Journal: Talanta 20100415

Title: Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

Journal: Digestive diseases and sciences 20100201

Title: Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study.

Journal: Indian journal of pharmacology 20100201

Title: Identification and determination of antihypertonics from the group of angiotensin-convertase inhibitors by densitometric method in comparition with HPLC method.

Journal: Acta poloniae pharmaceutica 20100101

Title: Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation.

Journal: Journal of pharmacy & bioallied sciences 20100101

Title: Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

Title: Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Journal: Current cardiology reviews 20090801

Title: Impact of statins and ACE inhibitors on mortality after COPD exacerbations.

Journal: Respiratory research 20090101

Title: [Preventive pharmacotherapy in arterial hypertension: problems of clinical assessment of drugs in women].

Journal: Kardiologiia 20090101

Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.

Journal: PloS one 20090101

Title: Stabilization of quinapril by incorporating hydrogen bonding interactions.

Journal: Indian journal of pharmaceutical sciences 20090101

Title: Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.

Journal: The Journal of pharmacology and experimental therapeutics 20081101

Title: The Effect of the Dried-Bonito Broth on Blood Pressure, 8-Hydroxydeoxyguanosine (8-OHdG), an Oxidative Stress Marker, and Emotional States in Elderly Subjects.

Journal: Journal of clinical biochemistry and nutrition 20081101

Title: [Clinico-economical efficacy of angiotensin converting enzyme inhibitors in patients with arterial hypertension and ischemic heart disease].

Journal: Kardiologiia 20080101

Title: The prince and the pauper. A tale of anticancer targeted agents.

Journal: Molecular cancer 20080101

Title: Moexipril and left ventricular hypertrophy.

Journal: Vascular health and risk management 20070201

Title: Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates)) 20070101

Title: [Assessment of the effect of angiotensin converting enzyme inhibitor moexipril on the functional state of vascular wall in patients with I - III degree arterial hypertension].

Journal: Kardiologiia 20070101

Title: Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry.

Journal: Journal of chromatographic science 20060401

Title: [Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].

Journal: Kardiologiia 20060101

Title: [Investigation of efficacy of cardiovascular drugs in women].

Journal: Kardiologiia 20060101

Title: [Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].

Journal: Kardiologiia 20060101

Title: [Moexipril and cardiovascular diseases in women: is there a reason for optimism?].

Journal: Kardiologiia 20060101

Title: [Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].

Journal: Kardiologiia 20060101

Title: [Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].

Journal: Kardiologiia 20060101

Title: Subchronic exposure to high-dose ACE-inhibitor moexipril induces catalase activity in rat liver.

Journal: Molecular and cellular biochemistry 20051201

Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.

Journal: Chemical research in toxicology 20050601

Title: MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.

Journal: International journal of cardiology 20050420

Title: Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.

Journal: American journal of therapeutics 20050101

Title: [Hemodynamic and anti-ischemic effects of moexipril in patients having postinfarction heart dysfunction and moderate left ventricular heart failure].

Journal: Klinicheskaia meditsina 20050101

Title: [The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density].

Journal: Kardiologiia 20050101

Title: [Moexipril influence on quality of life in postmenopausal women with arterial hypertension].

Journal: Terapevticheskii arkhiv 20050101

Title: [Assessment of antihypertensive efficacy of moexipril in metabolic syndrome].

Journal: Kardiologiia 20050101

Title: Pharmacological and clinical profile of moexipril: a concise review.

Journal: Journal of clinical pharmacology 20040801

Title: [Hypertension in postmenopausal women: medical and social significance and results of therapy with moexipril.].

Journal: Kardiologiia 20040101

Title: The influence of relative humidity and temperature on stability of moexipril hydrochloride in solid phase.

Journal: Acta poloniae pharmaceutica 20040101

Title: Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods.

Journal: Journal of pharmaceutical and biomedical analysis 20031015

Title: Pharmacological profile and clinical use of moexipril.

Journal: Expert review of cardiovascular therapy 20030901

Title: Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation.

Journal: Journal of endocrinological investigation 20030101

Title: ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20030101

Title: Systemic hypertension in postmenopausal women: a clinical approach.

Journal: Current hypertension reports 20021201

Title: Using ACE inhibitors appropriately.

Journal: American family physician 20020801

Title: Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition.

Journal: Journal of hypertension 20020501

Title: Should perindopril be used to treat patients with heart failure?

Journal: American family physician 20020501

Title: Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.

Journal: Acta cardiologica 20020201

Title: Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.

Journal: International journal of clinical pharmacology and therapeutics 20020101

Title: Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

Journal: Clinical pharmacokinetics 20020101

Title: Chemical reactivity in solid-state pharmaceuticals: formulation implications.

Journal: Advanced drug delivery reviews 20010516

Title: Protease inhibitors: current status and future prospects.

Journal: Journal of medicinal chemistry 20000210

Title: Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats.

Journal: European journal of pharmacology 19990528

Title: Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril.

Journal: Cardiovascular drugs and therapy 19980901

Title: Moexipril. A review of its use in the management of essential hypertension.

Journal: Drugs 19980601

Title: Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).

Journal: Cardiology 19980501

Title: Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.

Journal: Pharmacotherapy 19980101

Title: Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats.

Journal: The Journal of endocrinology 19970901

Title: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.

Journal: Arzneimittel-Forschung 19970201

Title: Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.

Journal: European journal of clinical pharmacology 19960101

Title: Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.

Journal: Journal of clinical pharmacology 19950301

Title: Evidence for site-specific absorption of a novel ACE inhibitor.

Journal: Pharmaceutical research 19890901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 103775-10-6
Tags:103775-10-6 Molecular Formula|103775-10-6 MDL|103775-10-6 SMILES|103775-10-6 3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-
Catalog No.: AA01DQ6Y
103775-10-6,MFCD00865878
103775-10-6 | 3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-
Pack Size: 10mg
Purity:
1 week
$697.00 $488.00
Pack Size: 50mg
Purity:
1 week
$1,322.00 $925.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01DQ6Y
Chemical Name: 3-Isoquinolinecarboxylic acid,2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-
CAS Number: 103775-10-6
MDL Number: MFCD00865878
Properties
Complexity: 742  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 3  
Heavy Atom Count: 36  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 2  
Rotatable Bond Count: 12  
XLogP3: 1.2  
Literature fold

Title: A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for moexipril, an angiotensin-converting enzyme inhibitor in human plasma.

Journal: Biomedical chromatography : BMC20121201

Title: Correlation between ultra-high performance liquid chromatography-tandem mass spectrometry and reversed-phase thin-layer chromatography hydrophobicity data for evaluation of angiotensin-converting enzyme inhibitors absorption.

Journal: Journal of chromatography. A20121005

Title: Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.

Journal: Bioorganic & medicinal chemistry letters20120115

Title: Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.

Journal: Journal of fluorescence20120101

Title: Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.

Journal: PloS one20120101

Title: First order derivative spectrophotometric and HPLC methods for determination of moexipril hydrochloride in the pure form, pharmeceutical formulations and evaluation of its stability.

Journal: Acta poloniae pharmaceutica20120101

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology20111201

Title: Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertension.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20110101

Title: Scope of claim coverage in patents of fufang Chinese herbal drugs: Substitution of ingredients.

Journal: Chinese medicine20110101

Title: Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models.

Journal: PloS one20110101

Title: Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method.

Journal: Healthcare informatics research20101201

Title: Anti-hypertensive drugs have different effects on ventricular hypertrophy regression.

Journal: Clinics (Sao Paulo, Brazil)20100701

Title: Determination of antihypertensive drug moexipril hydrochloride based on the enhancement effect of sodium dodecyl sulfate at carbon paste electrode.

Journal: Talanta20100415

Title: Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

Journal: Digestive diseases and sciences20100201

Title: Adverse drug reaction monitoring with angiotensin converting enzyme inhibitors: A prospective, randomized, open-label, comparative study.

Journal: Indian journal of pharmacology20100201

Title: Identification and determination of antihypertonics from the group of angiotensin-convertase inhibitors by densitometric method in comparition with HPLC method.

Journal: Acta poloniae pharmaceutica20100101

Title: Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation.

Journal: Journal of pharmacy & bioallied sciences20100101

Title: Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences20100101

Title: Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

Journal: Current cardiology reviews20090801

Title: Impact of statins and ACE inhibitors on mortality after COPD exacerbations.

Journal: Respiratory research20090101

Title: [Preventive pharmacotherapy in arterial hypertension: problems of clinical assessment of drugs in women].

Journal: Kardiologiia20090101

Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.

Journal: PloS one20090101

Title: Stabilization of quinapril by incorporating hydrogen bonding interactions.

Journal: Indian journal of pharmaceutical sciences20090101

Title: Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.

Journal: The Journal of pharmacology and experimental therapeutics20081101

Title: The Effect of the Dried-Bonito Broth on Blood Pressure, 8-Hydroxydeoxyguanosine (8-OHdG), an Oxidative Stress Marker, and Emotional States in Elderly Subjects.

Journal: Journal of clinical biochemistry and nutrition20081101

Title: [Clinico-economical efficacy of angiotensin converting enzyme inhibitors in patients with arterial hypertension and ischemic heart disease].

Journal: Kardiologiia20080101

Title: The prince and the pauper. A tale of anticancer targeted agents.

Journal: Molecular cancer20080101

Title: Moexipril and left ventricular hypertrophy.

Journal: Vascular health and risk management20070201

Title: Metabolism of moexipril to moexiprilat: determination of in vitro metabolism using HPLC-ES-MS.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))20070101

Title: [Assessment of the effect of angiotensin converting enzyme inhibitor moexipril on the functional state of vascular wall in patients with I - III degree arterial hypertension].

Journal: Kardiologiia20070101

Title: Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography-electrospray ionization mass spectrometry.

Journal: Journal of chromatographic science20060401

Title: [Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].

Journal: Kardiologiia20060101

Title: [Investigation of efficacy of cardiovascular drugs in women].

Journal: Kardiologiia20060101

Title: [Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].

Journal: Kardiologiia20060101

Title: [Moexipril and cardiovascular diseases in women: is there a reason for optimism?].

Journal: Kardiologiia20060101

Title: [Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril].

Journal: Kardiologiia20060101

Title: [Angiotensin converting enzyme inhibitor moexipril in the treatment of arterial hypertension. Possibilities of moexipril in the treatment of postmenopausal women].

Journal: Kardiologiia20060101

Title: Subchronic exposure to high-dose ACE-inhibitor moexipril induces catalase activity in rat liver.

Journal: Molecular and cellular biochemistry20051201

Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.

Journal: Chemical research in toxicology20050601

Title: MORE--MOexipril and REgression of left ventricle hypertrophy in combination therapy A multicentric open label clinical trial.

Journal: International journal of cardiology20050420

Title: Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.

Journal: American journal of therapeutics20050101

Title: [Hemodynamic and anti-ischemic effects of moexipril in patients having postinfarction heart dysfunction and moderate left ventricular heart failure].

Journal: Klinicheskaia meditsina20050101

Title: [The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density].

Journal: Kardiologiia20050101

Title: [Moexipril influence on quality of life in postmenopausal women with arterial hypertension].

Journal: Terapevticheskii arkhiv20050101

Title: [Assessment of antihypertensive efficacy of moexipril in metabolic syndrome].

Journal: Kardiologiia20050101

Title: Pharmacological and clinical profile of moexipril: a concise review.

Journal: Journal of clinical pharmacology20040801

Title: [Hypertension in postmenopausal women: medical and social significance and results of therapy with moexipril.].

Journal: Kardiologiia20040101

Title: The influence of relative humidity and temperature on stability of moexipril hydrochloride in solid phase.

Journal: Acta poloniae pharmaceutica20040101

Title: Simultaneous determination of moexipril hydrochloride and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods.

Journal: Journal of pharmaceutical and biomedical analysis20031015

Title: Pharmacological profile and clinical use of moexipril.

Journal: Expert review of cardiovascular therapy20030901

Title: Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation.

Journal: Journal of endocrinological investigation20030101

Title: ACE Inhibition with moexipril: a review of potential effects beyond blood pressure control.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20030101

Title: Systemic hypertension in postmenopausal women: a clinical approach.

Journal: Current hypertension reports20021201

Title: Using ACE inhibitors appropriately.

Journal: American family physician20020801

Title: Oestrogen action on the myocardium in vivo: specific and permissive for angiotensin-converting enzyme inhibition.

Journal: Journal of hypertension20020501

Title: Should perindopril be used to treat patients with heart failure?

Journal: American family physician20020501

Title: Reversal of left ventricular hypertrophy with the ACE inhibitor moexipril in patients with essential hypertension.

Journal: Acta cardiologica20020201

Title: Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.

Journal: International journal of clinical pharmacology and therapeutics20020101

Title: Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

Journal: Clinical pharmacokinetics20020101

Title: Chemical reactivity in solid-state pharmaceuticals: formulation implications.

Journal: Advanced drug delivery reviews20010516

Title: Protease inhibitors: current status and future prospects.

Journal: Journal of medicinal chemistry20000210

Title: Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats.

Journal: European journal of pharmacology19990528

Title: Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril.

Journal: Cardiovascular drugs and therapy19980901

Title: Moexipril. A review of its use in the management of essential hypertension.

Journal: Drugs19980601

Title: Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide).

Journal: Cardiology19980501

Title: Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors.

Journal: Pharmacotherapy19980101

Title: Impact of antihypertensive therapy on the skeleton: effects of moexipril and hydrochlorothiazide on osteopenia in spontaneously hypertensive ovariectomized rats.

Journal: The Journal of endocrinology19970901

Title: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.

Journal: Arzneimittel-Forschung19970201

Title: Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients.

Journal: European journal of clinical pharmacology19960101

Title: Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.

Journal: Journal of clinical pharmacology19950301

Title: Evidence for site-specific absorption of a novel ACE inhibitor.

Journal: Pharmaceutical research19890901

Building Blocks More >
1097874-78-6
1097874-78-6
1-Ethynyl-2,4,5-trifluorobenzene
AA01DRL8 | MFCD11655774
2092746-03-5
2092746-03-5
3-(5-chlorofuran-2-yl)-1h-pyrazole-4-carbaldehyde
AA01DSSJ | MFCD31629598
1487355-27-0
1487355-27-0
[3-(propan-2-yl)-1,2-oxazol-4-yl]methanamine
AA01DT8L | MFCD31559588
6726-65-4
6726-65-4
pyrazolo[3,2-c][1,2,4]triazin-4-ol
AA01DTBH | MFCD15203806
1275545-13-5
1275545-13-5
3-Quinolinecarboxylic acid, 6,8-dibromo-4-chloro-, ethyl ester
AA01DTJK | MFCD16181536
2057448-28-7
2057448-28-7
1-morpholino-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethan-1-one
AA01DTNH | MFCD31916116
2177258-86-3
2177258-86-3
8-Tert-Butyl3-Ethyl2,8-Diazaspiro[4.5]Decane-3,8-Dicarboxylate Mesylate
AA01DTU9 | MFCD28992034
2177259-39-9
2177259-39-9
(2S)-2-AMINO-2-(4-FLUORO-3-METHOXYPHENYL)ETHAN-1-OL HYDROCHLORIDE
AA01DU53 | MFCD24417821
1001159-02-9
1001159-02-9
Methyl 2-(3,4-difluorophenyl)-2-hydroxyacetate
AA01DUT6 | MFCD16693815
1157110-17-2
1157110-17-2
3-METHYLMORPHOLINE-4-SULFONAMIDE
AA01DUXE | MFCD12194648
Submit
© 2017 AA BLOCKS, INC. All rights reserved.